Cochlear Stock

Cochlear Net Income

The Net Income of Cochlear (COH.AX) as of Aug 12, 2026 is 388.90 M AUD. In the previous year, Net Income was 356.80 M AUD — a change of 9.00% (higher).

Net Income

388.90 MAUD

YoY

9.00%

Last updated:

In 2026, Cochlear's profit amounted to 388.90 M AUD, a 9.00% increase from the 356.80 M AUD profit recorded in the previous year.

The Cochlear Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

NET INCOME (M AUD)
Date
NET INCOME (M AUD)
Jan 1, 2024
356.80 base
Jan 1, 2025
388.90 base
Jan 1, 2026 (e)
310.29 base
Jan 1, 2027 (e)
345.05 base
Jan 1, 2028 (e)
378.40 base
Jan 1, 2029 (e)
417.52 base
Jan 1, 2030 (e)
433.00 base
Jan 1, 2031 (e)
685.12 base
YEARNET INCOME (M AUD)
2031 est 685.12
2030 est 433.00
2029 est 417.52
2028 est 378.40
2027 est 345.05
2026 est 310.29
2025 388.90
2024 356.80
2023 300.60
2022 289.10
2021 326.50
2020 -238.30
2019 276.70
2018 245.80
2017 223.62
2016 188.92
2015 145.84
2014 93.70
2013 132.60
2012 56.80
2011 180.10
2010 155.20
2009 130.50
2008 115.20
2007 100.10
2006 80.00
Access this data via the Eulerpool API

Cochlear Revenue

Cochlear Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
2.24 B AUD
509.60 M AUD
356.80 M AUD
Jan 1, 2025
2.34 B AUD
522.90 M AUD
388.90 M AUD
Jan 1, 2026 (e)
2.33 B AUD
538.74 M AUD
310.29 M AUD
Jan 1, 2027 (e)
2.42 B AUD
557.99 M AUD
345.05 M AUD
Jan 1, 2028 (e)
2.57 B AUD
592.59 M AUD
378.40 M AUD
Jan 1, 2029 (e)
2.69 B AUD
621.55 M AUD
417.52 M AUD
Jan 1, 2030 (e)
2.53 B AUD
582.72 M AUD
433.00 M AUD
Jan 1, 2031 (e)
3.55 B AUD
0.00 AUD
685.12 M AUD

Cochlear Margins

Cochlear stock margins

The Cochlear margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cochlear. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cochlear.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
74.86 %
22.79 %
15.96 %
Jan 1, 2025
73.74 %
22.32 %
16.60 %
Jan 1, 2026 (e)
73.74 %
23.07 %
13.29 %
Jan 1, 2027 (e)
73.74 %
23.07 %
14.27 %
Jan 1, 2028 (e)
73.74 %
23.07 %
14.73 %
Jan 1, 2029 (e)
73.74 %
23.07 %
15.50 %
Jan 1, 2030 (e)
73.74 %
23.07 %
17.15 %
Jan 1, 2031 (e)
73.74 %
0.00 %
19.28 %

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Net Income Details

Understanding Cochlear's Profit Margins

The profit margins of Cochlear represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Cochlear's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Cochlear's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Cochlear's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Cochlear’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Cochlear stock

Net Income of Cochlear is 388.90 M AUD in 2026.

Net Income of Cochlear changed from 356.80 M AUD to 388.90 M AUD, representing a 9.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Income Cochlear since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's Cochlear historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

Income Statement — Cochlear

All Key Metrics — Cochlear